Should we commit to eradicate malaria worldwide?

March 03, 2017

For Bruno Moonen, Deputy Director for malaria at the Global Health Program, eradication is the only equitable and sustainable solution.

He points out that the world has already committed to malaria eradication, albeit without a target date -- and that malaria endemic regions "are setting ambitious elimination targets, showing a clear demand for, and commitment to, regional elimination and, eventually, global eradication."

He believes the alternative, indefinite control, is not sustainable, saying this "would require constant investment in research and development to stay ahead of an ever evolving parasite and vector."

Countries that eliminate, on the other hand, are more likely to remain malaria-free," he writes. And he calls for a recommitment by the World Health Assembly to malaria eradication as "a strong sign of support for the regional elimination ambitions."

However, he argues that "this should not be a commitment to a campaign that is based on a single tool, effected through an all-in global effort that needs to continue everywhere until the last parasite is exterminated.

Instead, it should be "a global commitment to support parallel regional elimination efforts combined with sustained investments in research to develop the necessary tools and to tackle the yet unknown challenges of the future."

But Clive Shiff, Associate Professor at Johns Hopkins Bloomberg School of Public Health in Baltimore, believes the necessary huge investment could be better spent.

"We should promote the management of health services rather than commit massive funds to attempt to eradicate malaria in the near future," he writes.

His reasons include the fact that governments of many endemic countries have other priorities, while local wars as well as unstable, reluctant, or impoverished administrations, "mean many cannot commit the concerted effort necessary to achieve eradication."

He questions whether eradication efforts could be properly integrated and funded, and whether national health ministries could manage and coordinate the resources necessary for eradication.

Eradication requires elimination of all cases, even of subclinical infection, he explains, meaning that however implemented, eradication would be costly.

"Proper management of malaria seems the sensible route. Investing to integrate malaria control into functional local public health systems would be sustainable at a manageable expense. It would also help bolster local infrastructure and the local public health service as well as ensuring that malaria is kept under control and no longer of public health importance," he concludes.
-end-
Head to Head: Should we commit to eradicate malaria worldwide?

http://www.bmj.com/content/356/bmj.i916

About the journal

The BMJ has been at the forefront of innovative thinking and practice in healthcare since 1840 and is now the fourth most cited general medical journal in the world. For more information, visit the website.

BMJ

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.